BFG
GILD icon

Bleakley Financial Group’s Gilead Sciences GILD Stock Holding History

Bleakley Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.71M Buy
55,332
+24,649
+80% +$3.45M 0.12% 141
2025
Q4 		$3.77M Buy
30,683
+3,493
+13% +$424K 0.07% 229
2025
Q3 		$3.02M Sell
27,190
-254
-0.9% -$28.9K 0.07% 231
2025
Q2 		$3.04M Sell
27,444
-13,535
-33% -$1.44M 0.08% 223
2025
Q1 		$4.59M Buy
40,979
+15,495
+61% +$1.6M 0.15% 134
2024
Q4 		$2.35M Buy
25,484
+2,414
+10% +$217K 0.07% 227
2024
Q3 		$1.93M Buy
23,070
+1,947
+9% +$149K 0.06% 260
2024
Q2 		$1.45M Sell
21,123
-768
-4% -$51.3K 0.04% 334
2024
Q1 		$1.6M Buy
21,891
+10
+0% +$769 0.05% 330
2023
Q4 		$1.77M Buy
21,881
+1,869
+9% +$145K 0.06% 297
2023
Q3 		$1.5M Sell
20,012
-3,177
-14% -$244K 0.05% 310
2023
Q2 		$1.79M Sell
23,189
-1,451
-6% -$116K 0.06% 294
2023
Q1 		$2.04M Sell
24,640
-2,427
-9% -$201K 0.07% 250
2022
Q4 		$2.32M Buy
+27,067
New +$2.14M 0.08% 221

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bleakley Financial Group's GILD Position: Q1 2026 in Review

Bleakley Financial Group increased its Gilead Sciences (GILD) stake by 80% in Q1 2026, buying an estimated $3.45M and bringing the position to 55,332 shares worth $7.71M. The position accounts for 0.12% of the portfolio, ranked #141.

Bleakley Financial Group first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Bleakley Financial Group held 55,332 shares of Gilead Sciences worth $7.71M as of Q1 2026.
  • Bleakley Financial Group bought 24,649 Gilead Sciences shares in Q1 2026, an estimated $3.45M.
  • Gilead Sciences made up 0.12% of Bleakley Financial Group's portfolio in Q1 2026, its #141 holding.
  • Bleakley Financial Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Bleakley Financial Group's 13F filing for Q1 2026, filed 4 May 2026.